Historique
Article de Périodique
Initiation of buprenorphine during incarceration and retention in treatment upon release (2013)
Auteur(s) :
ZALLER, N. ;
McKENZIE, M. ;
FRIEDMANN, P. D. ;
GREEN, T. C. ;
McGOWAN, S. ;
RICH, J. D.
Année
2013
Page(s) :
222-226
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
ETATS-UNIS
Thésaurus mots-clés
PRISON
;
TRAITEMENT DE MAINTENANCE
;
BUPRENORPHINE
;
INCARCERATION
;
PRISE EN CHARGE
;
NALOXONE
;
INITIATION
Résumé :
We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners (N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively (p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively (p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment.
Affiliation :
The Miriam Hospital, Providence, RI, USA